Editas Medicine, Inc.
EDIT
$2.37
$0.2612.09%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 52.82% | 30.03% | -67.61% | 26.95% | 8.08% |
| Total Depreciation and Amortization | -60.69% | -4.33% | 38.81% | 823.04% | -113.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -21.42% | -33.66% | 63.65% | -1.00% | 99.08% |
| Change in Net Operating Assets | -138.35% | -126.23% | 245.59% | -378.84% | -32.31% |
| Cash from Operations | 38.57% | -5.05% | 5.84% | 3.47% | 7.84% |
| Capital Expenditure | -- | 100.00% | 78.89% | 81.51% | 16.40% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.87% | -24.78% | 79.38% | -63.75% | 56.72% |
| Cash from Investing | -7.21% | -24.36% | 82.14% | -63.14% | 61.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 131.64% | 416.52% | 433.46% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -105.20% | -- | -- |
| Cash from Financing | 131.64% | 615.80% | -102.59% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17,366.00% | -102.10% | -79.97% | 13.76% | 755.89% |